4559:TYO
Zeria Pharmaceutical Co Ltd
1 926,00 JP¥
arrow_upward
+0,63%(+12,00) 1D
7-окт., 15:04:03 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
1 910 JP¥
High
1 928 JP¥
Low
1 906 JP¥
Mkt. cap
96,53 млд
Avg. vol.
169,52 миң
Volume
72,80 миң
Dividend
2,54%
Quarterly dividend
12 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
10,32
52-wk high
2 434 JP¥
52-wk low
1 878 JP¥
EPS
187 JP¥
Shares outstanding
50,11 млн
No. of employees
2 миң
Open
1 910 JP¥
High
1 928 JP¥
Low
1 906 JP¥
Mkt. cap
96,53 млд
Avg. vol.
169,52 миң
Volume
72,80 миң
Dividend
2,54%
Quarterly dividend
12 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
10,32
52-wk high
2 434 JP¥
52-wk low
1 878 JP¥
EPS
187 JP¥
Shares outstanding
50,11 млн
No. of employees
2 миң
News stories
From web sources and news partners
Yahoo Finance
·
19 мүнөт мурун
Stock Market: Will S&P 500 Open Up or Down Today?
The Motley Fool
·
5 мүнөт мурун
Microsoft Stock Is on Track to Trail the S&P 500 for a 3rd Straight Year. History Says What Happened After Its Last 2 Streaks.
Trefis
·
28 мүнөт мурун
15 S&P 500 Stocks Just Made New 52-Week Highs
Investor's Business Daily
·
1 саат мурун
Dow Jones Futures: S&P 500 Hits High As Astera, GE Vernova, Arista Lead Buys, But These Stocks Tumble
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1,75 миң
Founded1955-ж., 22-дек.
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp